2m 2m 2m 2m 2m 2m 2m
KORRO BIO (KRRO)
NASDAQ
$10.92-$0.08 (-0.72%)
Price as of Jun 03, 2026 4:39 PM EDT- $193.4MMarket Cap
- -7.80%1-Year Change
- BiotechnologyIndustry
KORRO BIO (KRRO)
$10.92-$0.08 (-0.72%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.4M +181.46% | 2.3M N/A | 0 -100.00% | 3,000 -99.98% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 6.4M +181.46% | 2.3M N/A | 0 -100.00% | 3,000 -99.98% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -65.6M +3.05% | -63.6M +11.15% | -57.3M +15.85% | -49.4M -18.88% | |
Depreciation and Amortization Expense | 4.3M +20.06% | 3.6M -1.79% | 3.6M +31.24% | 2.8M -0.32% | |
Total Operating Expenses | 128.2M +36.17% | 94.2M +11.41% | 84.5M +1.85% | 83.0M -15.39% | |
Operating Profit | -121.9M +32.58% | -91.9M +8.73% | -84.5M +1.85% | -83.0M -1.22% | |
Interest Income | 5.2M -38.23% | 8.5M +149.93% | 3.4M +155.39% | 1.3M +234.26% | |
Interest Expense | N/A N/A | N/A N/A | 0 +100.00% | -961,000 +25.79% | |
Interest Income and Expense and Net | 5.2M -38.23% | 8.5M +149.93% | 3.4M +825.96% | 366,000 +199.73% | |
Total Nonoperating Income and Expense | 5.2M -38.23% | 8.5M +149.93% | 3.4M +220.93% | 1.1M +38.22% | |
Income before Taxes | -116.6M +39.77% | -83.4M +2.83% | -81.1M -0.54% | -81.6M -3.65% | |
Income Taxes | 637,000 +351.77% | 141,000 +422.22% | 27,000 +1,450.00% | -2,000 -113.33% | |
Extraordinary Items | 30.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -117.3M +40.30% | -83.6M +2.97% | -81.2M -0.50% | -81.6M -3.67% | |
Net Income from Continuing Operations Applicable to Common | -116.6M +39.77% | -83.4M +2.83% | -81.1M -0.54% | -81.6M -3.65% | |
Basic EPS and Net Income | -12.48 +33.19% | -9.37 -82.35% | -53.08 N/A | N/A N/A | |
Diluted EPS and Net Income | -12.48 +33.19% | -9.37 -82.35% | -53.08 N/A | N/A N/A | |
Basic Weighted Average Shares | 9.4M +5.32% | 8.9M +483.30% | 1.5M N/A | N/A N/A | |
Diluted Weighted Average Shares | 9.4M +5.32% | 8.9M +483.30% | 1.5M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 21.8M -60.78% | 55.6M -66.51% | 166.2M +219.80% | 52.0M -34.76% | |
Short-Term Investments | 53.3M -24.30% | 70.5M N/A | 0 -100.00% | 31.1M -39.02% | |
Cash and Cash Equivalents and Short-Term Investments | 75.2M -40.40% | 126.1M -24.11% | 166.2M +99.95% | 83.1M -36.42% | |
Total Current Assets | 82.4M -37.37% | 131.5M -23.85% | 172.7M +97.42% | 87.5M -35.07% | |
Accumulated Depreciation | 10.6M +44.23% | 7.3M -6.55% | 7.8M +20.72% | 6.5M +55.26% | |
Property and Plant and Equipment and Net | 8.2M -70.54% | 27.7M +76.89% | 15.7M +471.92% | 2.7M -50.40% | |
Total Long-Term Assets | 2.5M -11.62% | 2.8M +3.06% | 2.7M -0.91% | 2.7M -50.40% | |
Total Assets | 113.5M -49.83% | 226.2M +2.06% | 221.7M +82.83% | 121.2M -34.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 10.0M +1,100.48% | |
Total Current Liabilities | 11.9M -20.21% | 15.0M -23.22% | 19.5M -7.34% | 21.0M +83.97% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 4.2M -70.59% | |
Total Long-Term Liabilities | 1.5M +0.61% | 1.5M +39.79% | 1.1M +1,083.15% | 89,000 +2.30% | |
Total Liabilities | 62.1M -5.71% | 65.8M +27.19% | 51.8M -0.56% | 52.0M -4.57% | |
Retained Earnings | -383.8M +43.99% | -266.6M +45.67% | -183.0M -30.06% | -261.7M +45.30% | |
Total Stockholders Equity | 51.4M -67.93% | 160.4M -5.59% | 169.9M +145.55% | 69.2M -47.11% | |
Total Shares Outstanding | 9.4M +0.43% | 9.4M +16.97% | 8.0M -77.27% | 35.3M +1.88% | |
Cash Flow | |||||
Cash from Operating Activities | -78.6M +30.77% | -60.1M -10.71% | -67.3M +15.53% | -58.2M -23.43% | |
Capital Expenditures | 518,000 -97.11% | 17.9M +128.46% | 7.8M N/A | 0 -100.00% | |
Cash from Investing Activities | 44.0M +135.67% | -123.3M -1,204.86% | 11.2M -64.14% | 31.1M +147.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 685,000 -99.01% | 69.4M -63.06% | 187.8M +32,640.90% | -577,000 -142.49% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,906.37% -52.90% | -4,047.12% N/A | N/A N/A | -2,766,733.33% +462,333.76% | |
Return on Assets | -69.03% +84.96% | -37.32% -21.17% | -47.34% -11.03% | -53.22% +41.42% | |
Return on Equity | -110.70% +118.75% | -50.61% -25.47% | -67.90% -16.77% | -81.57% +55.71% | |
Revenue Growth | 181.46% N/A | N/A N/A | -100.00% +0.02% | -99.98% +60.97% | |
Current Ratio | 6.90 -21.51% | 8.79 -0.83% | 8.87 +113.05% | 4.16 -64.71% | |
Cash Ratio | 1.83 -50.85% | 3.72 -56.38% | 8.53 +245.13% | 2.47 -64.54% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.20 +78.47% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.12 +44.50% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow